As expected, cleaved PARP and cleaved caspase-3 increased with significant differences between pre-treatment group (0 Gy) and low/high dose of irradiation-treated cervical cancer tissues (Figure 3Ad and Bb). The gene discussed is CASP3; the disease is cervical carcinoma.